T4	Effect 0 18	Progressive anemia
T6	Subject 92 138	a patient with metastatic renal cell carcinoma
T8	Sub-Disorder 107 138	metastatic renal cell carcinoma
T9	Drug 54 70	interferon-alpha
T10	Drug 75 88	interleukin-2
T5	Treatment 29 88	combination therapy with interferon-alpha and interleukin-2
